noom glp 1 companion GLP-1 Closing the GLP-1 Care Gap
Description
Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medication: pills.
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic poly-peptide (GIP, previously known as gastric inhibitory polypeptide) are key incretin
One of the best parts of my job is being a Day 1 investor in companies like @Ro (776 co) led by CEOs like @ZReitano solving real problems for folks thru technology
Depending on your medical history, additional tests may also be required.
Eli Lillys decision to hike the UK list price of its weight-loss drug Mounjaro by as much as 170% isnt just about affordability
It also provides key minerals that help regulate appetite and support metabolic balance
